LIMN (Liminatus Pharma) Accounts Payable: $0.53 Mil (As of Mar. 2026)


LIMN Liminatus Pharma Inc LIMN
13 GF Score
Price $0.11
! 1 Warning Sign
View Full Analysis

What is Liminatus Pharma Accounts Payable?

Liminatus Pharma LIMN -6.99% 13 Accounts Payable is $0.53 Mil as of Mar. 2026. GuruFocus rates LIMN with a GF Score™ of 13/100. The stock has 1 warning sign investors should review.

Liminatus Pharma's Accounts Payable for the quarter that ended in Mar. 2026 was $0.53 Mil.

Liminatus Pharma's quarterly Accounts Payable increased from Sep. 2025 ($0.56 Mil) to Dec. 2025 ($0.58 Mil) but then declined from Dec. 2025 ($0.58 Mil) to Mar. 2026 ($0.53 Mil).

Liminatus Pharma's annual Accounts Payable increased from Dec. 2023 ($0.93 Mil) to Dec. 2024 ($1.48 Mil) but then declined from Dec. 2024 ($1.48 Mil) to Dec. 2025 ($0.58 Mil).

Liminatus Pharma Accounts Payable Related Terms

Liminatus Pharma Accounts Payable Historical Data

* Premium members only.

The historical data trend for Liminatus Pharma's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Liminatus Pharma Accounts Payable Chart

Liminatus Pharma Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Accounts Payable
0.51 0.93 1.48 0.58

Liminatus Pharma Quarterly Data
Dec22 Mar23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.43 0.56 0.58 0.53
LIMN
13GF Score
Liminatus Pharma Inc LIMN
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Liminatus Pharma Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.53 Mil mean?
Liminatus Pharma (LIMN) has a Accounts Payable of $0.53 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Liminatus Pharma and its competitors.
Is Liminatus Pharma's Accounts Payable too high?
Liminatus Pharma's current Accounts Payable is $0.53 Mil. Overall, Liminatus Pharma has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Liminatus Pharma's Accounts Payable compare to GNPX and PCSA?
Liminatus Pharma's Accounts Payable of $0.53 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Liminatus Pharma and its competitors. Liminatus Pharma's current Accounts Payable is $0.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Liminatus Pharma stock overvalued right now?
Liminatus Pharma (LIMN) has a current Accounts Payable of $0.53 Mil. The current Accounts Payable is $0.53 Mil. Liminatus Pharma's overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Liminatus Pharma (LIMN), the current Accounts Payable is $0.53 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Liminatus Pharma Business Description

Address 12611 Hiddencreek Way, Unit C, Cerritos, CA, USA, 90703
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company engaged in developing cancer therapies and treatments. The company is developing a next generation CD47 immune checkpoint inhibitor that enables cancer cells to evade detection by the immune system. Anti-CD47 monoclonal antibodies generally induce anemia and thrombocytopenia due to their binding to red blood cells and platelets. The Liminatus CD47 mAb has shown to preferentially bind to immune cells, but not to red blood cells and platelets and does not induce hemolysis. The clinical candidate is currently in the late preclinical stage.
13GF Score

Get the complete analysis for LIMN

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.11
Price